Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from FDA
688062.SHSHANGHAI, Aug. 19, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D code: 7MW4911) received IND clearance from the U.S. Food and Drug Administration (FDA). The clearance...
August 19, 2025Clinical Trials
Read more →